恒瑞医药再签重磅BD交易,建信中证创新药ETF(159835)所跟踪指数涨超1%,机构:中国本土创新药已进入“工程师红利”兑现期

东方财富
Sep 25, 2025

截至2025年9月25日 13:01,中证创新药产业指数(931152)上涨1.12%,样本股奥赛康(002755)上涨10.02%,九洲药业(603456)上涨6.41%,信立泰(002294)上涨4.43%,恒瑞医药(600276),荣昌生物(688331)等个股均上涨。9月24日,恒瑞医药公告称,将公司具有自主知识产权的1类创新药瑞康曲妥珠单抗(SHR-A1811)项目有偿许可给...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10